EV/EBITDA
112.56
-0.52-0.46%
97 min ago
Summary
- As of February 8, 2025, AKBA EV/EBITDA is 112.56, with a fall of -0.52 (-0.46%) during the most recent trading day.
- Over the past year, AKBA EV/EBITDA has increased by +151.80 (+386.85%).
- AKBA EV/EBITDA is now -56.16% below its all-time high of 256.75.
Performance
AKBA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKBA EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -0.5% | -0.5% | -0.5% |
1 m1 month | +13.9% | +13.9% | +14.4% |
3 m3 months | +16.9% | +16.9% | +17.5% |
6 m6 months | +108.6% | +93.7% | +88.6% |
ytdytd | +12.7% | +12.7% | +13.1% |
1 y1 year | +386.9% | +49.1% | +31.1% |
5 y5 years | +2886.1% | -51.6% | -74.8% |
AKBA EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -10.1% | 93.26 | +20.7% | |
3 m | 3-month | 125.25 | -10.1% | 93.26 | +20.7% |
6 m | 6-month | 125.25 | -10.1% | 53.11 | +111.9% |
1 y | 1-year | 256.75 | -56.2% | -55.60 | +302.4% |
3 y | 3-year | 256.75 | -56.2% | -55.60 | +302.4% |
5 y | 5-year | 256.75 | -56.2% | -55.60 | +302.4% |
alltime | all time | 256.75 | -56.2% | -55.60 | +302.4% |
Akebia Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | 112.56(+12.7%) |
2024 | 99.91(-435.0%) |
2023 | -29.82(+935.4%) |
2022 | -2.88(+68.4%) |
2021 | -1.71(+87.9%) |
2020 | -0.91(-69.2%) |
Date | Value |
---|---|
2019 | -2.95(-6.9%) |
2018 | -3.17(-62.2%) |
2017 | -8.39(+431.0%) |
2016 | -1.58(-72.0%) |
2015 | -5.64(+4.6%) |
2014 | -5.39 |
FAQ
- What is Akebia Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akebia Therapeutics?
- What is AKBA EV/EBITDA year-to-date change?
- What is Akebia Therapeutics EV/EBITDA year-on-year change?
What is Akebia Therapeutics EV/EBITDA?
The current EV/EBITDA of AKBA is 112.56
What is the all time high EV/EBITDA for Akebia Therapeutics?
Akebia Therapeutics all-time high EV/EBITDA is 256.75
What is AKBA EV/EBITDA year-to-date change?
Akebia Therapeutics EV/EBITDA has changed by +12.65 (+12.66%) since the beginning of the year
What is Akebia Therapeutics EV/EBITDA year-on-year change?
Over the past year, AKBA EV/EBITDA has changed by +151.80 (+386.85%)